Hyperimmune Plasma and Immunoglobulins against COVID-19: A Narrative Review
Since late 2019, the new SARS-CoV-2 virus belonging to the <i>Coronaviridae</i> family has been responsible for COVID-19 pandemic, a severe acute respiratory syndrome. Several antiviral therapies, mostly derived from previous epidemics, were initially repurposed to fight this not rarely...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/14/2/214 |